| Financial Year |
March 31 2023 |
| Monetary Funds |
341,921,311.41 |
| Held-for-trading Financial Assets |
320,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
246,774,268.04 |
| Advances to Suppliers |
1,435,223.19 |
| Other Receivables |
2,580,134.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
162,074,878.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,342,451.21 |
| Total Current Assets |
1,094,442,160.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,000,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
264,017,553.55 |
| Under-construction Projects |
24,377,102.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,885,156.89 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,736,992.10 |
| Deferred Income Tax Assets |
12,892,914.49 |
| Other Non-Current Assets |
2,204,390.91 |
| Sub-Total of Non-Current Assets |
388,494,307.87 |
| Total Assets |
1,482,936,468.44 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,050,857.01 |
| Accounts Payable |
211,509,438.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,576,060.94 |
| Taxes Payable |
970,344.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,875,583.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,319,777.09 |
| Other Current Liabilities |
46,159.35 |
| Sub-Total of Current Liabilities |
267,476,898.99 |
| Long-term Loans |
2,654,952.48 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
543,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,313,578.70 |
| Total Liabilities |
270,790,477.69 |
| Paid-In Capital(Or Share Stock) |
212,833,460.00 |
| Capital Surplus |
638,953,117.60 |
| Surplus Reserve |
36,307,072.13 |
| LESS:Treasury Stock |
25,111,993.09 |
| Undistributed Profits |
348,308,570.71 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,212,145,990.75 |
| Owner's Equity（Stockholder's Equity） |
1,212,145,990.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,482,936,468.44 |
